GLP1R and intestinal obstruction: While the cohort was relatively small and sample sizes differed substantially (87.9% GLP-1 vs 12.1% comparator), the authors reported an increased risk of bowel obstruction in those treated with GLP-1RAs (HR 4.22 [95% CI 1.02-17.40]).